Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.3016
-0.0048 (-1.57%)
At close: May 15, 2026, 4:00 PM EDT
0.3070
+0.0054 (1.79%)
After-hours: May 15, 2026, 7:59 PM EDT
Cosmos Health Revenue
In the year 2025, Cosmos Health had annual revenue of $65.27M with 19.93% growth. Cosmos Health had revenue of $19.70M in the quarter ending December 31, 2025, with 38.52% growth.
Revenue (ttm)
$65.27M
Revenue Growth
+19.93%
P/S Ratio
0.24
Revenue / Employee
$400,441
Employees
163
Market Cap
15.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.27M | 10.85M | 19.93% |
| Dec 31, 2024 | 54.43M | 1.05M | 1.97% |
| Dec 31, 2023 | 53.38M | 3.03M | 6.02% |
| Dec 31, 2022 | 50.35M | -5.89M | -10.48% |
| Dec 31, 2021 | 56.24M | 833.40K | 1.50% |
| Dec 31, 2020 | 55.41M | 15.73M | 39.65% |
| Dec 31, 2019 | 39.68M | 2.59M | 6.99% |
| Dec 31, 2018 | 37.08M | 7.07M | 23.56% |
| Dec 31, 2017 | 30.01M | 23.26M | 344.28% |
| Dec 31, 2016 | 6.76M | 6.22M | 1,165.53% |
| Dec 31, 2015 | 533.80K | -7.11M | -93.01% |
| Dec 31, 2014 | 7.64M | 6.74M | 746.55% |
| Dec 31, 2013 | 902.37K | - | - |
| Dec 31, 2012 | - | - | - |
| Jul 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 403.43B |
| Cencora | 328.68B |
| Cardinal Health | 250.74B |
| Henry Schein | 13.38B |
| Accendra Health | 2.72B |
| 111, Inc. | 1.80B |
| EDAP TMS | 74.07M |
| Synergy CHC | 30.38M |
COSM News
- 1 day ago - Cosmos Health pursues research, development financing program with EIB - TheFly
- 1 day ago - Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program - Accesswire
- 3 days ago - Cosmos Health announces withdrawal of registration statement on Form S-1 - TheFly
- 3 days ago - Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 - Accesswire
- 4 days ago - Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months - Accesswire
- 7 days ago - Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed - Accesswire
- 15 days ago - Cosmos Health sees over $2.5M incremental annual revenue from Cur18 in U.S. - TheFly
- 15 days ago - Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months - Accesswire